Bayer builds emerging markets presence through Indian JV with Zydus
This article was originally published in Scrip
Executive Summary
Bayer HealthCare and Zydus Cadila have signed an agreement to form a 50:50 joint venture company, Bayer Zydus Pharma, to handle the sales and marketing of pharmaceutical products in India. The alliance, which sidesteps the conventional mergers and brand acquisition models but offers similar gains, is aimed at pooling expertise and building market presence.